Clinuvel Pharmaceuticals (CLVLY)

[FarmaZutical]

The new logo is absolutely horrible. And the website is overloaded and difficult to navigate. Not to mention the Latin crap.

But the product is still the same and it’s a winner.

It seems, Vitiligo is still in their radar. They post a lot about it on FB and Instagram.

Down the road we might see Scenesse being trial for a range of CNS disorders. In a recent patent filing they mention Multiple Sclerosis, Alzheimer's Disease and other dementias, Parkinson's Disease, Amyotrophic Lateral Sclerosis (ALS) and which is also called Lou Gehrig's Disease, Huntington's Disease, Degenerative Nerve Diseases, Encephalitis, Epilepsy, Genetic Brain Disorders, Head and Brain Malformations, Hydrocephalus, Stroke, and Prion Diseases.

Here and now focus is on the NDA for EPP and then probably Vitiligo.

EPP alone warrants a much higher pps.